Real-World Clinical Burden of Newly Diagnosed Heart failure in Thai Patients

to related objects

Location: Deutsche Nationalbibliothek Frankfurt am Main

Extent: 1 Online-Ressource.

Language: Englisch

Bibliographic citation: Real-World Clinical Burden of Newly Diagnosed Heart failure in Thai Patients ; volume:13 ; number:2 ; day:6 ; month:5 ; year:2024 ; pages:415-430 ; date:6.2024
Cardiology and therapy ; 13, Heft 2 (6.5.2024), 415-430, 6.2024

Creator: Boonyapiphat, Thanita
Tangkittikasem, Thidaporn
Torpongpun, Artit
Senthong, Vichai
Jiampo, Panyapat

Contributor: SpringerLink (Online service)

DOI: 10.1007/s40119-024-00366-5

URN: urn:nbn:de:101:1-2407240751200.008153023126

Rights: Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.

Last update: 14.08.2025, 10:57 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.

Show original at data provider

Associated

Boonyapiphat, Thanita
Tangkittikasem, Thidaporn
Torpongpun, Artit
Senthong, Vichai
Jiampo, Panyapat
SpringerLink (Online service)

Other Objects (12)

Real-World Heart Failure Burden in Thai Patients

Austria-based real-world data on bevacizumab in newly diagnosed epithelial ovarian cancer

Treatment Satisfaction and Burden of Illness in Patients with Newly Diagnosed Multiple Myeloma

Comparison between newly diagnosed hypertension in diabetes and newly diagnosed diabetes in hypertension

Once-weekly versus twice-weekly bortezomib in newly diagnosed multiple myeloma: a real-world analysis

Real-world prognostic significance of attaining minimal residual disease negativity in newly diagnosed multiple myeloma

$Evolution of economic burden of heart failure by ejection fraction in newly diagnosed patients in Spain$

Evolution of economic burden of heart failure by ejection fraction in newly diagnosed patients in Spain

Treatment patterns and comorbid burden of patients newly diagnosed with multiple sclerosis in the United States

Interstitial photodynamic therapy for newly diagnosed glioblastoma

Chronic Diarrhea Secondary to Newly Diagnosed VIPoma

Burden and presentation of depression among newly diagnosed individuals with TB in primary care settings in Ethiopia

Clinical comparisons between previously diagnosed SLE and newly diagnosed SLE by kidney biopsy

Real-World Heart Failure Burden in Thai Patients

Austria-based real-world data on bevacizumab in newly diagnosed epithelial ovarian cancer

Treatment Satisfaction and Burden of Illness in Patients with Newly Diagnosed Multiple Myeloma

Comparison between newly diagnosed hypertension in diabetes and newly diagnosed diabetes in hypertension

Once-weekly versus twice-weekly bortezomib in newly diagnosed multiple myeloma: a real-world analysis

Real-world prognostic significance of attaining minimal residual disease negativity in newly diagnosed multiple myeloma

$Evolution of economic burden of heart failure by ejection fraction in newly diagnosed patients in Spain$

Evolution of economic burden of heart failure by ejection fraction in newly diagnosed patients in Spain

Treatment patterns and comorbid burden of patients newly diagnosed with multiple sclerosis in the United States

Interstitial photodynamic therapy for newly diagnosed glioblastoma

Chronic Diarrhea Secondary to Newly Diagnosed VIPoma

Burden and presentation of depression among newly diagnosed individuals with TB in primary care settings in Ethiopia

Clinical comparisons between previously diagnosed SLE and newly diagnosed SLE by kidney biopsy

Real-World Heart Failure Burden in Thai Patients

Austria-based real-world data on bevacizumab in newly diagnosed epithelial ovarian cancer

Treatment Satisfaction and Burden of Illness in Patients with Newly Diagnosed Multiple Myeloma

Comparison between newly diagnosed hypertension in diabetes and newly diagnosed diabetes in hypertension

Once-weekly versus twice-weekly bortezomib in newly diagnosed multiple myeloma: a real-world analysis

Real-world prognostic significance of attaining minimal residual disease negativity in newly diagnosed multiple myeloma

$Evolution of economic burden of heart failure by ejection fraction in newly diagnosed patients in Spain$

Evolution of economic burden of heart failure by ejection fraction in newly diagnosed patients in Spain

Treatment patterns and comorbid burden of patients newly diagnosed with multiple sclerosis in the United States

Interstitial photodynamic therapy for newly diagnosed glioblastoma

Chronic Diarrhea Secondary to Newly Diagnosed VIPoma

Burden and presentation of depression among newly diagnosed individuals with TB in primary care settings in Ethiopia

Clinical comparisons between previously diagnosed SLE and newly diagnosed SLE by kidney biopsy

Cultural heritage institutions wishing to register will find more information here.

Fields marked * need to be filled in.

Username*

Please enter your username

Email*

Please enter your email address

Please do not fill this field

First name

Last name

Password*

Please enter your password

Confirm password*

Please enter the same password

I have read the terms of use and the privacy policy for the collection of personal data and accept them. *

This field is required.

I would like to subscribe to the newsletter of the Deutsche Digitale Bibliothek. See newsletter subscription info.

Account created

Your "My DDB" account has been successfully created. Before you can log in to your account, you must click the confirmation link in the message we just sent to the email address you provided.

Real-World Clinical Burden of Newly Diagnosed Heart failure in Thai Patients

Object Details

References and Relationships

Contributors, Places and Time

Further information

Data provider

Associated

Other Objects (12)

Real-World Heart Failure Burden in Thai Patients

Austria-based real-world data on bevacizumab in newly diagnosed epithelial ovarian cancer

Treatment Satisfaction and Burden of Illness in Patients with Newly Diagnosed Multiple Myeloma

Comparison between newly diagnosed hypertension in diabetes and newly diagnosed diabetes in hypertension

Once-weekly versus twice-weekly bortezomib in newly diagnosed multiple myeloma: a real-world analysis

Real-world prognostic significance of attaining minimal residual disease negativity in newly diagnosed multiple myeloma

Evolution of economic burden of heart failure by ejection fraction in newly diagnosed patients in Spain

Treatment patterns and comorbid burden of patients newly diagnosed with multiple sclerosis in the United States

Interstitial photodynamic therapy for newly diagnosed glioblastoma

Chronic Diarrhea Secondary to Newly Diagnosed VIPoma

Burden and presentation of depression among newly diagnosed individuals with TB in primary care settings in Ethiopia

Clinical comparisons between previously diagnosed SLE and newly diagnosed SLE by kidney biopsy

Real-World Heart Failure Burden in Thai Patients

Austria-based real-world data on bevacizumab in newly diagnosed epithelial ovarian cancer

Treatment Satisfaction and Burden of Illness in Patients with Newly Diagnosed Multiple Myeloma

Comparison between newly diagnosed hypertension in diabetes and newly diagnosed diabetes in hypertension

Once-weekly versus twice-weekly bortezomib in newly diagnosed multiple myeloma: a real-world analysis

Real-world prognostic significance of attaining minimal residual disease negativity in newly diagnosed multiple myeloma

Evolution of economic burden of heart failure by ejection fraction in newly diagnosed patients in Spain

Treatment patterns and comorbid burden of patients newly diagnosed with multiple sclerosis in the United States

Interstitial photodynamic therapy for newly diagnosed glioblastoma

Chronic Diarrhea Secondary to Newly Diagnosed VIPoma

Burden and presentation of depression among newly diagnosed individuals with TB in primary care settings in Ethiopia

Clinical comparisons between previously diagnosed SLE and newly diagnosed SLE by kidney biopsy

Real-World Heart Failure Burden in Thai Patients

Austria-based real-world data on bevacizumab in newly diagnosed epithelial ovarian cancer

Treatment Satisfaction and Burden of Illness in Patients with Newly Diagnosed Multiple Myeloma

Comparison between newly diagnosed hypertension in diabetes and newly diagnosed diabetes in hypertension

Once-weekly versus twice-weekly bortezomib in newly diagnosed multiple myeloma: a real-world analysis

Real-world prognostic significance of attaining minimal residual disease negativity in newly diagnosed multiple myeloma

Evolution of economic burden of heart failure by ejection fraction in newly diagnosed patients in Spain

Treatment patterns and comorbid burden of patients newly diagnosed with multiple sclerosis in the United States

Interstitial photodynamic therapy for newly diagnosed glioblastoma

Chronic Diarrhea Secondary to Newly Diagnosed VIPoma

Burden and presentation of depression among newly diagnosed individuals with TB in primary care settings in Ethiopia

Clinical comparisons between previously diagnosed SLE and newly diagnosed SLE by kidney biopsy

Related objects

Reset password